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Abstract
Background: The protozoan Toxoplasma gondii is a pathogen that causes severe opportunistic disease in a wide
range of hosts. Efficient methods to diagnose acute T. gondii infection are essential for the administration of
appropriate treatments and to reduce economic losses. In animals with acute infections, circulating antigens (CAgs)
were detected as early as two days post-infection; these CAgs were reliable diagnostic indicators of acute infection.
However, only a limited number of CAgs have been identified to date. The objective of this study was to identify a
broader spectrum of CAgs and to explore novel diagnostic candidates in serum.
Methods: A canine model of acute toxoplasmiosis was established. For this purpose, six dogs were infected by
intraperitoneal inoculation of tachyzoites. The CAgs spectrum in the serum was identified with the
immunoprecipitation-shotgun approach. Two CAgs with low homology to other species, coronin protein (TgCOR)
and ELMO protein (TgELMO), were heterologously expressed in Escherichia coli. Polyclonal antibodies against these
two proteins were prepared, and the presence of these proteins in the serum was verified by Western blotting. The
two CAgs were detected and evaluated by indirect ELISA methods.
Results: The CAgs levels peaked between two and five days after inoculation, and twenty-six CAgs were identified.
Western blotting showed the presence of the two proteins in the serum during acute infection. Based on ELISA
tests, the two CAgs were detected during acute infection.
Conclusions: We identified twenty-six CAgs in the serum of canines with experimental acute toxoplasmosis and
discovered two novel diagnostic candidates. We also provide new insights into the diagnosis of acute
toxoplasmosis.
Keywords: Toxoplasma gondii, Acute infection, Proteomics, Circulating antigens, Diagnostic candidates
Background
Toxoplasma gondii can cause serious opportunistic in-
fections in a wide range of hosts [1]. This species has
tremendous disease-causing potential because it can in-
vade any nucleated cell, resulting in lysis of the host cells
[1]. The symptoms of T. gondii acute infection in
humans range from mild flu-like symptoms in most people
to more severe complications in immunocompromised
individuals or following trans-placental transmission to a
foetus [2, 3]. During the first or second trimester of preg-
nancy, infection with T. gondii could potentially lead to the
parasite passing through the placenta to the foetus, result-
ing in mental retardation, retinochoroiditis, blindness, and
even death [4, 5]. The available therapies of acute toxoplas-
mosis are not fully effective. Thus, it is crucial to diagnose
T. gondii infection and make efforts to reduce toxoplasmo-
sis transmission [6]. If an acute infection cannot be
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diagnosed in time, the optimal period for treatment will
also be missed [7].
Laboratory tests are the main diagnostic method for
acute T. gondii infection. Indirect (serological methods)
and direct (PCR, in situ hybridization, isolation and hist-
ology) methods have been used to diagnose acute T. gondii
infection [8]. In general, serological diagnosis methods are
based on the detection of specific antibodies (IgG, IgM
and IgA) [9, 10]. Antibodies are commonly produced in
the late stage of acute infection or during chronic infec-
tion. Detection based on molecular biology methods is
limited because specific equipment is required that is not
universally available in clinical laboratories. Isolation and
identification of the parasite requires extensive experience
and is time-consuming. The lack of efficient diagnostic
methods for acute T. gondii infection can lead to therapy
failure, and there is an urgent need to identify new diag-
nostic candidates.
The T. gondii invasion process is rapid and dynamic and
relies on the secretion of numerous proteins from micro-
nemes, rhoptries and dense granules [11]. Excretory/
secretory antigens (ESA) are a group of antigens from T.
gondii that represent the majority of circulating antigens
(CAgs) in the sera of hosts during acute toxoplasmosis
and the reactivation of infection [12–14]. Recent evidence
strongly suggests that CAgs can serve as serological
markers to diagnose acute infection [15, 16]. To date, only
a limited number of CAgs have been identified. Moreover,
the identification of CAgs is meaningful for the diagnosis
of acute T. gondii infections. The aim of this study was to
identify the spectrum of T. gondii CAgs using the
immunoprecipitation-LC-MS/MS technique. We also
evaluated the use of antibodies to identify novel candidate
molecules for the detection of acute toxoplasmosis by
ELISA tests.
Methods
T. gondii, cell culture and animal preparations
The T. gondii RH strain is an international standard viru-
lent strain that is widely used for Toxoplasma analysis. A
virulent strain is also advantageous to successfully establish
an acute T. gondii infection model. The T. gondii strain RH
and Vero cells were stored in our laboratory. Vero cells
were propagated at 37 °C in a 5 % CO2 atmosphere in
DMEM (Dulbecco modified Eagle medium) supplemented
with 10 % FBS, 2 mmol/l glutamine, 100 kU/l streptomycin,
and 400 kU/l penicillin. T. gondii were grown and main-
tained in Vero cells.
Female BALB/c mice (~25 g body weight) were pur-
chased from the Shanghai Laboratory Animal Centre at
the Chinese Academy of Science (Shanghai, China). Six
clean female beagles (3 months old; ~4 kg body weight)
without pathogens that obviously interfere with scientific
experiments were purchased from the Shanghai Xingang
Laboratory Animal Farm (Shanghai, China). All of the
animals used in the experiments were raised in a steril-
ized room and fed sterilized food and water at the Animal
Laboratory Centre at the Shanghai Veterinary Research
Institute. The study was approved by the Animal Care
and Use Committee of the Shanghai Veterinary Research
Institute. The animals were handled in strict accordance
with the animal protection law of the People’s Republic of
China (released on 09/18/2009) and the National Stan-
dards for Laboratory Animals in China (executed on 05/
1/2002).
Excretory/secretory antigens and antisera preparation
Excretory/secretory antigens were prepared according to
previously described methods [14]. Briefly, 3 × 109 purified
tachyzoites were suspended in 15 ml DMEM and incubated
at 37 °C for 2 h. Tachyzoites were removed by centrifuga-
tion at 1,000 g for 15 min (at 4 °C). The supernatant was
supplemented with a protease inhibitor cocktail (Merck,
Darmstadt, Germany, Cat No. 535140) and concentrated to
500 μl using a 3 kDa centrifugal filter (Merck, Cat No.
UFC900308). The ESA protein concentration was deter-
mined using a DC protein assay reagent package (Bio-Rad,
Hercules, USA, Cat No. 500-0120). Two groups of two fe-
male BALB/c mice were immunized. Two mice were
immunised with EAS and two mice were immunised with
PBS as a control. The 206 adjuvant (Seppic, Paris, France)
was used according to the manufacturer’s instructions. In
total, 100 μg ESA was injected into each mouse at 0, 2, 4, 6
and 8 weeks. Equal doses of PBS were used to immunize
the control group mice. Blood sera were sampled from the
tails of mice at 10 days after each immunization. To detect
the ESA antisera, immunoblotting and ELISA assays were
performed using standard methods.
Development of acute infection models
Three dogs that were intraperitoneally inoculated with
1 × 109 purified tachyzoites were treated as the test
group. Three dogs that were intraperitoneally inocu-
lated with the same volume of sterile PBS were treated
as a control group. A 3 ml volume of blood was col-
lected twice per day between days 1 and 3 and once per
day between days 4 and 18. Blood was then collected
once every 3 days until two months had elapsed. Each
blood sample was divided into 2 tubes (one tube for
serum separation and one tube for sodium citrate antic-
oagulation). The sera were used to detect CAgs or to
purify CAgs by immunoprecipitation. Centrifuged sera
(4,000 rpm for 10 min) from blood not treated with an
anticoagulant were supplemented with a protease in-
hibitor cocktail (Merck, Cat No. 535140) and stored at
-80 °C until use. The anticoagulant blood was used to
extract DNA for T. gondii detection.
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Evaluation of an acute infection model by ELISA and
nested PCR
To test for CAgs, an ELISA assay was performed using
a commercial Circulating Antigen Detection ELISA
(CA-ELISA) kit (Combined Company, Shenzhen,
China). The results are presented as the mean value
and standard error (SE) of the sample absorbance
from 3 dog groups.
To detect T. gondii in the blood, a genomic DNA ex-
traction kit (SBS Gentech, Shanghai, China) was used to
extract DNA from whole blood samples. Nested-PCR was
conducted as described in our earlier study [17]. The
protozoa rDNA sequence contains 5'-IGS-18S rDNA-
ITS1-5.8S rDNA-ITS2-28S rDNA-IGS-3'. Based on the
sequence of the ITS1-5.8S rDNA-ITS2 gene (GenBank
Accession No. X75453) of T. gondii, two pairs of nested
PCR primers were designed. The forward primer 5'-ACC
TTT GAA TCC CAA GCA-3' and the reverse primer 5'-
TAA ATC GGA CAA ACG CCC-3' were used to amplify
an 855 bp fragment representing the outer amplicon. The
forward primer 5'-TTT GCA TTC AAG AAG CGT G-3'
and the reverse primer 5'-AAG GTG CCA TTT GCG
TTC-3' were used to amplify a 432 bp fragment represent-
ing the inner amplicon. The primers were used at 0.4 μM
each in the 25 μl reaction system. Each reaction used 1 μl
of the extracted DNA, 9.5 μl double-distilled water, 12.5 μl
of the 2 × PCR mix (Dongsheng Biotech, Guangzhou,
China), which consisted of 100 mM KCl, 20 mM Tris-
HCl, 3 mM MgCl2, 400 μM dNTPs and 0.1U/μl Taq DNA
polymerase. After an initial denaturation at 94 °C for
5 min, amplification consisted of 30 cycles of denaturation
at 94 °C for 50 s, annealing at 55 °C for 40 s and extension
at 72 °C for 45 s. Finally, the DNA fragments were ex-
tended at 72 °C for 10 min.
Immunoprecipitation
Serum (10 μl) was sampled on days 2 and 3 post-
challenge with T. gondii. Sera from each of the 3 beagles
were combined (60 μl). The mixed serum was diluted with
540 μl sterile PBS (pH 7.4). Protein A agarose beads
(100 μl, 25 %, Beyotime, Nantong, China, Cat No. P2006)
were added, and the sample was stirred at 4 °C for 2 h to
eliminate serum antibodies. The mixture was centrifuged
at 4 °C at 2,500 rpm for 5 min. After that, the supernatant
was collected. Protein G agarose beads (100 μl, 25 %,
Beyotime, Cat No. P2009) and 5 μl (1 μg) normal mouse
IgG was added to eliminate non-specific binding and then
the sample was agitated at 4 °C for 2 h. After centrifuga-
tion, the supernatant was collected as described above.
Then, 5 μl ESA antiserum was added to the supernatant
and the mixture was stirred at 4 °C overnight. Protein G
agarose beads (100 μl, 25 %, Beyotime) were added and
then stirred at 4 °C for 3 h. The mixture was centrifuged
at 2,500 rpm for 5 min to collect the beads. The beads
were washed 3 times with PBS and then boiled with 60 μl
sodium dodecylsulfate polyacrylamide gel electrophoresis
(SDS-PAGE) sample buffer for 5 min. The sample was
centrifuged at 2,500 rpm for 5 min, and the supernatant
was collected for LC-MS/MS detection and 8 % polyacryl-
amide gel electrophoresis analysis.
Filter-aided proteome preparation
The supernatant was supplemented with DTT (to a final
concentration of 100 mM) and boiled for 5 min. After
cooling, 200 μl UA buffer (8 M Urea, 150 mM Tris-HCl,
pH 8.0) was added. The sample was then mixed. The li-
quid was transferred to a 10 kDa Millipore Amicon
Ultra-4 centrifugal filter device and centrifuged at
14,000 rpm for 15 min. Another 200 μl UA buffer were
added, and the sample was centrifuged as described
above. The filtrate was discarded, and 100 μl iodoaceta-
mide (50 mM iodoacetamide in UA) was added. The
tube was shaken at 600 rpm for 1 min and then incu-
bated at room temperature in the dark for 30 min. After
being centrifuged at 14,000 rpm for 10 min, the solution
was dialyzed against 100 μl UA buffer twice and then di-
alyzed against 100 μl dissolution buffer (25 mM
NH4HCO3) 3 times. The mixture treated with 40 μl
buffered trypsin (2 μg trypsin in 40 μl dissolution buffer)
and then incubated at 37 °C for 18 h. The incubated so-
lution was centrifuged at 14,000 rpm for 10 min, and the
supernatant was used for LC-MS/MS analysis [18].
Liquid chromatography (LC) - electrospray ionization (ESI)
tandem MS (MS/MS) analysis using a Q Exactive mass
spectrometer
Experiments were performed using a Q Exactive mass spec-
trometer coupled to an Easy nLC (Thermo Fisher Scientific,
Waltham, USA). The peptide mixture was loaded onto a
C18-reverse phase column (15 cm long, 75 μg inner diam-
eter) packed in-house with RP-C18 5 μm resin in buffer A
(0.1 % formic acid in HPLC-grade water). Peptides were
separated with a linear gradient of buffer B (0.1 % Formic
acid in 84 % acetonitrile) at a flow rate of 250 nl/min over
60 min. MS data were acquired using a data-dependent
top10 method by dynamically choosing the most abundant
precursor ions from the survey scan (300–1800 m/z) for
HCD (Higher-energy collisional dissociation) fragmenta-
tion. Determination of the target value was based on pre-
dictive Automatic Gain Control (pAGC). The dynamic
exclusion duration was 20 s. The survey scans were ac-
quired at a resolution of 70,000 at 200 m/z. The resolution
for the HCD spectra was set to 17,500 at 200 m/z. The nor-
malized collision energy was 27 eV. The underfill ratio,
which specifies the minimum percentage of the target value
likely to be reached at the maximum fill time, was defined
as 0.1 %. The instrument was run with the peptide recogni-
tion mode enabled.
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ESI mass spectrometry data analysis
The MS/MS spectra were used to search the UniProt
database (26,517 sequences, downloaded on June 13th,
2014) with the MASCOT engine (Matrix Science, version
2.2). To identify proteins, the following options were used:
Peptide mass tolerance = 20 ppm; MS/MS tolerance =
0.1 Da; Enzyme = Trypsin; Missed cleavage = 2; Fixed
modification: carbamidomethyl (C); Variable modification:
Oxidation (M); mascot score ≥ 20; and FDR < 0.01 at the
peptide and protein levels.
Bioinformatics analysis
To better understand the biological functions of the identi-
fied proteins, GO annotation was performed based on
BLAST results using the ToxoDB (http://toxodb.org/toxo/),
QuickGO (http://www.ebi.ac.uk/QuickGO) and DAVID v.
6.7 (http://david.abcc.ncifcrf.gov) databases [19–21].
Protein expression and antibody production
To further verify the CAgs components present in the
serum, coronin protein (TgCOR) and ELMO/CED 12
family protein (TgELMO), which both have low homology
to other species were selected for further evaluation of
their diagnostic value. The secondary structures of TgCOR
(GenBank Accession No. EPT25607.1) and TgELMO
(GenBank Accession No. XP_002367438.1) were analysed
using Protean DNAStar software. Hydrophilicity, surface
accessibility and antigenicity prediction schemes were used.
TgCOR and TgELMO were expressed using an E. coli (BL
21) expression system and the pET-28a-c(+) vector. The
recombinant plasmids were sent to Invitrogen Company
for full-length sequencing. The protein-coding regions,
primers, restriction enzymes and cut sites, expression data
and the theoretical molecular weights of the proteins are
shown in Table 1. The transformed cells with expression
vectors were grown in LB medium containing 50 μg/ml
ampicillin at 37 °C with vigorous shaking until the optical
density (600 nm) of the medium reached 0.6. The expres-
sion was induced by 0.5 mM isopropyl β-D-1-thiogalacto-
pyranoside (IPTG) and the culture was incubated at 20 °C
for 18 h. Collected cells were lysed by sonication. Recom-
binant proteins isolated from inclusion bodies were
refolded by a refolding kit (Novagen, Darmstadt, Germany,
CAT No. 70123-3) and purified using Ni-NTA His-Bind
resin (Novagen). Recombinant proteins were dialysed and
endotoxin was removed using the Triton-X114 method
[22]. Briefly, Triton X-114 was added to the protein solu-
tion (final concentration of Triton X 114 was 2 %, W/V).
After being mixed by vortex, the solution was incubated
on ice for 15 min and then at 50 °C for 5 min. The super-
natant was collected after centrifugation (12,000 g, 1 min,
30 °C. Protein concentrations were measured using a DC
protein assay reagent kit (Bio-Rad, USA). BALB/c mice
were immunized with each protein at a dose of 100 μg per
mouse. The immunization procedures and the detection of
antibody titres (Table 1) were performed as described
above. Blood samples were collected 10 days after the sec-
ond booster injection.
Verification of circulating antigens in the sera in an acute
infection model
To verify the presence of the identified CAgs in the sera
of animals with acute T. gondii infections, sera from the
test group were analysed by Western blotting at a dilution
of 1:10. Mixed serum from the control group was used as
a negative control. Antiserum for TgCOR and TgELMO
was treated as the primary antibody at a dilution of
1:2,000 and 1:4,000, respectively. HRP-conjugated goat
anti-mouse IgG (Jackson, USA) was used as a secondary
antibody at a dilution of 1:4,000. The detection of signals
on the membranes was performed using an Enhanced
Chemiluminescence (ECL) Kit (Thermo Fisher Scientific,
Waltham, USA).
Analysis of the diagnostic value of TgCOR and TgELMO
proteins
To evaluate the use of ELISA methods for clinical diag-
nosis, sera collected from the 6 dogs in the initial 16 days
post-infection were assessed for CAgs. Microwell plates
with 96 wells were coated (100 μl/well) with serum sam-
ples in carbonate buffer at a dilution of 1:50. TgCOR
and TgELMO antiserum was used as the primary anti-
body at a dilution of 1:1,000 and 1:2,000, respectively.
HRP-conjugated goat anti-mouse IgG (Jackson, USA)
was used as a secondary antibody at a dilution of
1:4,000. The results are presented as the absorbance
value for each sample.













TgCOR H211-A621 FP:55'-GTCGGATCCCACGATGGATCGAAGGCAT -3' BamHI Inclusion body 50,494.01 1:8000
RP: 5'-CGCCTCGAGAGCGGCTTCGTCCTGA -3' XhoI
TgELMO G1613 -L1916 FP:5'- TCTGGATCCGGGTCTCCGAGGTA -3' BamHI Soluble 39,203.52 1:4000
RP: 5'- AAGGTCGACTAGACCGGACGGAG -3' SalI
aEnzyme cleavage sites were underlined
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Results
An acute model of T. gondii infection in canines using
inoculation with tachyzoites was established successfully
The T. gondii strain RH is lethal when used to inoculate
mice; the death rate is also high in rabbit models of acute
RH strain infection. Small rabbits are also unsuitable for
the continuous collection of large amounts of blood. To en-
sure the collection of adequate amounts of sera, an acute
canine infection model was established in this trial. Our
early experiments showed that dogs (~7 kg body weight)
did not display symptoms of acute infection if inoculated
with less than 1 × 108 tachyzoites. In this study, the dogs
showed fever symptoms 24 h post-T. gondii infection
(Fig. 1a). Toxoplasma gondii and CAgs could be detected in
the blood after infection. The levels of CAgs peaked be-
tween 2 and 5 days after inoculation. The curve of CAgs
levels was similar to that of body temperature. CAgs were
gradually cleared away concomitant with the disappearance
of T. gondii (Fig. 1b, c). These results demonstrate the suc-
cessful development of an acute T. gondii infection model.
Circulating antigens enriched and purified by
immunoprecipitation were identified by LC-MS/MS
ESA antibodies could be used to identify numerous ESA
components with good immunogenicity (Fig. 2). The
molecular weights of the vast majority of identified CAgs
were greater than 15 kDa (Fig. 3a). In total, 220 protein
groups were identified by LC-MS/MS (Additional file 1).
Among these proteins, the unique peptide counts for 26
proteins were equal to or greater than 2. The proteins
identified by immunoprecipitation-shotgun analysis were
classified into the following major categories: microne-
mal proteins (MIC1, MIC3 and MIC4), dense granule
proteins (GRA1 and GRA5), surface antigens (SAG1 and
SAG2), novel CAg proteins (coronin, ELMO and
ribosomal-ubiquitin protein L40) and others (Table 2).
Bioinformatics Analysis
To better understand the functions of CAgs in biological
processes during acute T. gondii infection, GO analysis
was performed on 26 high-confidence proteins. Twenty
proteins were successfully annotated based on biological
process or cellular component and classified accordingly
(Table 2 and Fig. 3b). Among the annotated proteins,
25 % were involved in protein metabolism, 20 % were in-
volved in binding, 15 % were involved in carbohydrate
metabolism, 10 % were involved in oxidation-reduction
processes, 10 % localized to extracellular regions, and
5 % were involved in responses to stress, nucleoside me-
tabolism processes and phagocytosis. The other 5 %
were membrane components.
The two CAgs were detected during acute infection by T.
gondii
Considering the results of the BLAST analyses of 8 novel
CAgs, we chose 2 (coronin and ELMO) with low homology
to other species to further assess their diagnostic value. Sec-
ondary structure prediction revealed that TgCOR and
TgELMO had excellent hydrophilicity and antigenicity in
the regions H211–A621 and G1613–L1916, respectively.
Peptides containing good hydrophilic domains and antigen
epitopes were successfully expressed in an E. coli system
Fig. 1 Analyses of body temperature, CAgs and nested-PCR. a Body temperature between 1 to 16 days post-infection. b Sera from days 0 to 16
were tested for CAgs levels using a commercial Circulating Antigen Detection ELISA (CA-ELISA) Kit. Values represent the mean and standard error
from two groups. c Nested-PCR results. Lane M: marker; Lane N: negative control; Lanes 1–12: Nested-PCR results from day 1 to day 12 post-inoculation.
The nested-PCR results from one dog in the test group are shown
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(Fig. 4a, b). Mixed sera from the test group and control
group were analysed by Western blotting. Antiserum for
TgCOR or TgELMO was treated as the primary antibody,
respectively. The results showed that the 2 novel CAgs
identified in this study were present in the sera from ca-
nines with acute infections (Fig. 4c). The two circulating an-
tigens reached the highest level between day 2 and day 5.
However, TgCOR and TgELMO were undetectable at 12
and 14 days after inoculation, respectively (Figs. 5a, b).
TgELMO in the blood was detectable longer than TgCOR,
which might be due to the slower clearance rate and lower
ELISA detection background of TgELMO.
Discussion
Diagnosis of acute T. gondii infection
Molecular biological methods (PCR, real-time PCR and
Loop-mediated isothermal amplification) can be used to
diagnose acute T. gondii infection [23, 24]. However,
these methods are limited because specific equipment is
required. Serological methods have been widely used
Fig. 2 ESA antibodies were tested by ELISA and immunoblotting analyses. a Levels of ESA antibodies after each immunization. Two groups of 2
female BALB/c mice were immunized five times at 2-week intervals. PBS was used to immunize 2 mice in the control group. Blood sera were sampled
from the tails of mice 10 days after immunization. Each sample was measured in duplicate. Values represent the mean and standard deviation. b Western
blotting analysis of ESA. Lane 1: marker on gel; Lane 2: ESA on gel; Lane 3: marker on NC membrane; Lane 4: ESA on NC membrane. The membranes
were coloured with 3, 3’-diaminobenzidine
Fig. 3 SDS-PAGE analysis and GO annotation of CAgs enriched and purified by immunoprecipitation. a Circulating antigens enriched and purified
by immunoprecipitation were analysed by SDS-PAGE (8 %). Lane 1: marker; Lane 2: immunoprecipitation supernatant. b Pie charts showing the
GO distributions for the identified circulating antigens based on the major biological process or cell component categories. Twenty of the
identified proteins were successfully annotated
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1 D8L558 MIC4 4 4 8.62 63,061/5.05 [36, 37] Protein metabolic
process
2 S8F3P1 MIC1 3 3 4.17 48,628/5.15 [37] Binding
3 T2FG71 MIC3 2 2 7.81 35,165/5.97 [38] Unknown
Dense granules
4 P13403 GRA1 4 3 25.79 20,149/4.18 [39] Extracellular region
5 S7UP40 GRA5 2 2 13.33 12,976/5.78 [40] Extracellular region
Surface
6 S7V2Y4 SAG1 4 4 15.77 34,828/8.34 [41] Membrane
7 I7CQQ5 SAG2 2 2 19.18 14,814/6.17 [41] Unknown
Novel CAg proteins
8 S7VXR0 RPL40 3 3 26.36 14,685/9.84 na Protein metabolic
process
9 S8ETG3 Coronin 3 3 3.70 68,441/5.5 na Protein metabolic
process
10 S8GEU1 ELMO 2 2 0.71 243,844/9.91 na Phagocytosis
11 S8GDY4 Uncharacterized
protein
2 2 0.51 295,608/6.23 na Unknown




2 2 0.99 211,754/4.91 na Unknown
14 V4ZM84 Uncharacterized
protein
2 2 0.65 235,435/5.95 na Unknown
15 V4YZ80 Ubiquitin-transferase 2 2 0.09 1,711,013/6.68 na Protein metabolic
process
Other
16 S7VTE3 Protein disulfide
isomerase




14 11 41.34 35,548/6.03 [43, 44] Oxidation-reduction
process
18 S7VNC9 Actin 9 7 24.39 32,058/5.66 [45] Binding
19 S8GUS9 ACT1 3 2 4.52 41,907/5.05 [45] Binding
20 S7W8N1 Chaperonin protein
BiP (HSP70)
4 4 5.54 73,252/5.23 [46] Response to stress
21 S8G950 Enolase 2 3 3 10.53 52,113/6.43 [47] Carbohydrate
metabolic process








3 3 3.43 131,361/5.85 [50] Carbohydrate
metabolic process
25 Q2HXR1 Phosphorylase family
protein
2 2 8.58 33,042/6.66 [51] Nucleoside
metabolic process
26 S8GL48 Type I fatty acid
synthase
2 2 0.21 1,093,457/5.96 [52] Oxidation-reduction
process
aResults include proteins that have a unique peptide count ≥ 2
bSequence coverage is defined as the ratio (%) of matched residues in the entire sequence
cTheoretical Mr/pI was obtained from Uniprot database
dThe functions are classified by gene ontology (GO) annotations
Abbreviation: na, not available
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because they are easy to perform. To date, diagnosis of
T. gondii infection is mainly based on IgG detection in
the blood. However, IgG is only detectable at thirteen
days after infection [25]. Also, IgG persists in the blood
for a long period and might not represent an acute
infection [25]. IgM ELISA and complement fixation tests
are the most sensitive methods currently [9], but new-
borns might not produce IgM antibodies, and IgM pro-
duction might be delayed because maternal IgG can be
transmitted to the foetus through the placenta. Because
acute infection might be caused by a recurrent infection,
IgM is also rarely produced in immunocompromised
patients [10, 26].
As primary toxoplasmosis usually manifests as a flu-like
illness in immunocompetent individuals, these cases are
often not brought to the attention of the medical personnel
and symptoms soon pass without chemotherapy. However,
when T. gondii infection spreads in humans and animals in
an epidemic manner or occurs in immunosuppressed indi-
viduals, rapid diagnosis of acute toxoplasmosis becomes
particularly important. In cases where acutely infected indi-
viduals do seek medical attention, the drugs available for
treating influenza do not effectively kill T. gondii tachy-
zoites. Inefficient diagnosis of acute T. gondii infection will
lead to the spread and treatment delays of toxoplasmosis.
We also propose to detect the CAgs of T. gondii if the
patients experience flu-like symptoms before or during
pregnancy. If CAgs tests are positive, emergency strategies
such as drug therapies should be taken.
The presence of circulating antigens in blood represents
an acute infection
Serological diagnosis of acute T. gondii infection is usually
based on the detection of specific antibodies (IgM). How-
ever, the presence of IgM antibodies is not always indicative
of active toxoplasmosis. IgM can be produced for 6 months
after acute infection and remain in the body fluid for up to
18 months or even a few years [27–29]. The presence of
IgM during the chronic phase of T. gondii infection might
lead to unnecessary diagnostic risks and treatment side
Fig. 4 Expression and Western blotting of TgCOR and TgELMO. a, b Recombinant TgCOR and TgELMO expressed in E. coli were purified with Ni-NTA
His-Bind resin. c Western blotting of TgCOR and TgELMO. Mixed serum samples from the test group on day 3 were analysed by Western blotting at a
dilution of 1:10. Mixed serum samples from the control group were treated as a negative control. The protein bands on the NC membrane were displayed
using an ECL kit
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effects. These risk factors might even lead to the termin-
ation of pregnancy [27, 30].
Previous studies have developed acute T. gondii infec-
tion models in mice or rabbits by intraperitoneal inocula-
tion of tachyzoites. CAgs can be successfully detected
with serological methods in animal models [28, 31] and
CAgs have also been detected in the blood of rabbits and
pigs infected by oral inoculation of oocysts [25]. In the
sera of women and children with acute infection, CAgs
are also detectable [32]. The previous studies demonstrate
that the route of infection does not affect CAgs produc-
tion. In this study, acute T. gondii infection of canines was
successfully modelled by intraperitoneal inoculation of
tachyzoites. CAgs, markers of acute infection, were also
detected in this model.
Acute T. gondii infection can be diagnosed by direct
detection of CAgs [33]. The diagnosis of acute T. gondii
infection by CAgs detection is more sensitive than test-
ing for the whole parasite [34]. Although CAgs are
partly neutralized by blood antibodies, immunogenic
CAgs remain in the blood and can be detected using
high levels of specific antibodies [28]. Previous ELISA
results showed that the amount of CAgs in women and
children with acute infection are significantly higher
than that of chronic patients and healthy individuals,
which show no differences [32]. CAgs do not persist in
the blood for a long period of time [28].
Selection of multiple CAgs for diagnosis can improve the
reliability of diagnostic results
Some CAgs have been used to diagnose acute T. gondii in-
fection [31]. SAG1, SAG2, MIC1, MIC3 and GRA1 are
proteins identified in this study that have also been studied
for use in diagnostic assays [35]. The screening of multiple
diagnostic markers is helpful to improve the sensitivity and
specificity of diagnosis. The dynamic change of diagnostic
candidate molecules in the blood reflects the course of an
acute infection. First, the amount of antigen used for sero-
logical diagnosis must achieve the minimum detection
limit. Multiple molecules represent a large range of CAgs
and are more stable than single CAg molecule in the blood.
Identification of multiple CAgs and candidate diagnostic
molecules will improve the sensitivity of detection for acute
infection. Secondly, identification of the protein profile for
CAgs will improve the screening range of highly specific
antigens and minimize the effect of nonspecific binding on
diagnosis. This study identified 26 CAgs components and
analysed the preliminary application of two proteins for the
detection of CAgs to provide a theoretical basis for the
development of sensitive, specific and convenient immuno-
logical diagnostic techniques. Furthermore, this study
showed that TgCOR and TgELMO are detectable with
serological methods during active toxoplasmosis. The two
antigens change in a manner consistent with body
temperature and T. gondii levels in blood and disappear
within five days after the disappearance of T. gondii in the
blood.
However, whether antibodies against two recombinant
proteins can be widely used to diagnosis acute infection
and whether they can be used to effectively distinguish
acute and chronic infections in clinical applications re-
quires a large clinical trial for verification. Diagnosis of
Toxoplasma by detecting specific CAg also has the po-
tential to reduce the subsequent molecular diagnostic
Fig. 5 Detection of TgCOR and TgELMO in serum with the ELISA method using antisera. The average OD value for negative samples was multiplied
by 2.1 to obtain the cut-off value. The horizontal lines represent cut-off values. The two circulating antigens in the serum of each canine were detected
with a polyclonal antibodies against recombinant TgCOR and b TgELMO
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procedures during acute infection. In general, rapid and
accurate diagnosis of acute infection will lead to appro-
priate therapeutic interventions.
Conclusions
In summary, we identified 26 circulating antigens in the
sera of canines infected with T. gondii. Among these
CAgs molecules, 2 novel candidates were identified as
diagnostic antigens for Toxoplasma. Based on the de-
scribed CAgs, diagnostic methods were developed. Fur-
ther analysis of these methods will be performed in the
future and represents improvement in the detection ef-
ficiency of Toxoplasma.
Additional file
Additional file 1: Table S1. List of CAg proteins identified by LC-MS/
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